Literature DB >> 18023836

HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes.

Ritu Goila-Gaur1, Mohammad A Khan, Eri Miyagi, Sandra Kao, Sandrine Opi, Hiroaki Takeuchi, Klaus Strebel.   

Abstract

HIV-1 Vif inhibits the antiviral activity of APOBEC3G (APO3G) by inducing proteasomal degradation. Here, we studied the effects of Vif on APO3G in vitro. In this system, Vif did not cause APO3G degradation. Instead, Vif induced changes in APO3G that affected immunoprecipitation of the native protein. This effect required wt Vif and was reversed by heat denaturation of APO3G. Sucrose gradient analysis demonstrated that wt Vif induced the gradual transition of APO3G translated in vitro or expressed in HeLa cells from a low molecular mass conformation to puromycin-sensitive high molecular mass (HMM) complexes. In the absence of Vif or the presence of biologically inactive Vif APO3G failed to form HMM complexes. Our results expose a novel function of Vif that promotes the assembly of APO3G into presumably packaging-incompetent HMM complexes and may explain how Vif can overcome the APO3G-imposed block to HIV replication under conditions of no or inefficient APO3G degradation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023836      PMCID: PMC2396953          DOI: 10.1016/j.virol.2007.10.017

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  43 in total

1.  Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.

Authors:  Andrew Mehle; Joao Goncalves; Mariana Santa-Marta; Mark McPike; Dana Gabuzda
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

2.  Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization.

Authors:  Michael J Wichroski; Kozi Ichiyama; Tariq M Rana
Journal:  J Biol Chem       Date:  2004-11-10       Impact factor: 5.157

3.  The HIV 'A' (sor) gene product is essential for virus infectivity.

Authors:  K Strebel; D Daugherty; K Clouse; D Cohen; T Folks; M A Martin
Journal:  Nature       Date:  1987 Aug 20-26       Impact factor: 49.962

4.  Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein.

Authors:  M K Karczewski; K Strebel
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

5.  Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.

Authors:  Ya-Lin Chiu; Vanessa B Soros; Jason F Kreisberg; Kim Stopak; Wes Yonemoto; Warner C Greene
Journal:  Nature       Date:  2005-04-13       Impact factor: 49.962

6.  Extract-specific heterogeneity in high-order complexes containing apolipoprotein B mRNA editing activity and RNA-binding proteins.

Authors:  S G Harris; I Sabio; E Mayer; M F Steinberg; J W Backus; J D Sparks; C E Sparks; H C Smith
Journal:  J Biol Chem       Date:  1993-04-05       Impact factor: 5.157

7.  Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes.

Authors:  J H Simon; T E Southerling; J C Peterson; B E Meyer; M H Malim
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.

Authors:  Hui Chen; Caroline E Lilley; Qin Yu; Darwin V Lee; Jody Chou; Iñigo Narvaiza; Nathaniel R Landau; Matthew D Weitzman
Journal:  Curr Biol       Date:  2006-03-07       Impact factor: 10.834

9.  Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation.

Authors:  Jason F Kreisberg; Wes Yonemoto; Warner C Greene
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

10.  Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells.

Authors:  Sandra Kao; Eri Miyagi; Mohammad A Khan; Hiroaki Takeuchi; Sandrine Opi; Ritu Goila-Gaur; Klaus Strebel
Journal:  Retrovirology       Date:  2004-09-17       Impact factor: 4.602

View more
  32 in total

1.  HIV-1 Vif promotes the G₁- to S-phase cell-cycle transition.

Authors:  Jiangfang Wang; Emma L Reuschel; Jason M Shackelford; Lauren Jeang; Debra K Shivers; J Alan Diehl; Xiao-Fang Yu; Terri H Finkel
Journal:  Blood       Date:  2010-12-13       Impact factor: 22.113

2.  Molecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif.

Authors:  Sean R Marcsisin; John R Engen
Journal:  J Mol Biol       Date:  2010-08-20       Impact factor: 5.469

3.  Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Authors:  Judd F Hultquist; Reuben S Harris
Journal:  Future Virol       Date:  2009-11-01       Impact factor: 1.831

Review 4.  Functions and regulation of the APOBEC family of proteins.

Authors:  Harold C Smith; Ryan P Bennett; Ayse Kizilyer; William M McDougall; Kimberly M Prohaska
Journal:  Semin Cell Dev Biol       Date:  2011-10-06       Impact factor: 7.727

5.  Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif.

Authors:  Tayyba T Baig; Yuqing Feng; Linda Chelico
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

Review 6.  Functions and Malfunctions of Mammalian DNA-Cytosine Deaminases.

Authors:  Sachini U Siriwardena; Kang Chen; Ashok S Bhagwat
Journal:  Chem Rev       Date:  2016-09-01       Impact factor: 60.622

7.  Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif.

Authors:  Robert C Walker; Mohammad A Khan; Sandra Kao; Ritu Goila-Gaur; Eri Miyagi; Klaus Strebel
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

8.  APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

Authors:  Jinhui Li; Yan Chen; Ming Li; Michael A Carpenter; Rebecca M McDougle; Elizabeth M Luengas; Patrick J Macdonald; Reuben S Harris; Joachim D Mueller
Journal:  J Mol Biol       Date:  2013-12-17       Impact factor: 5.469

9.  A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.

Authors:  Gongying Chen; Zhiwen He; Tao Wang; Rongzhen Xu; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

Review 10.  The APOBEC3 family of retroelement restriction factors.

Authors:  Eric W Refsland; Reuben S Harris
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.